Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Tobacco Genomics: Complexity and Translational Challenges.

Bergen AW, Do EK, Chen LS, David SP.

Nicotine Tob Res. 2019 May 21;21(6):705-706. doi: 10.1093/ntr/ntz033. No abstract available.

PMID:
31111930
2.

Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?

Panagiotou OA, Schuit E, Munafò MR, Bennett DA, Bergen AW, David SP.

Nicotine Tob Res. 2019 Aug 19;21(9):1289-1293. doi: 10.1093/ntr/ntz009.

PMID:
30690475
3.

Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use.

Brazel DM, Jiang Y, Hughey JM, Turcot V, Zhan X, Gong J, Batini C, Weissenkampen JD, Liu M; CHD Exome+ Consortium; Consortium for Genetics of Smoking Behaviour, Barnes DR, Bertelsen S, Chou YL, Erzurumluoglu AM, Faul JD, Haessler J, Hammerschlag AR, Hsu C, Kapoor M, Lai D, Le N, de Leeuw CA, Loukola A, Mangino M, Melbourne CA, Pistis G, Qaiser B, Rohde R, Shao Y, Stringham H, Wetherill L, Zhao W, Agrawal A, Bierut L, Chen C, Eaton CB, Goate A, Haiman C, Heath A, Iacono WG, Martin NG, Polderman TJ, Reiner A, Rice J, Schlessinger D, Scholte HS, Smith JA, Tardif JC, Tindle HA, van der Leij AR, Boehnke M, Chang-Claude J, Cucca F, David SP, Foroud T, Howson JMM, Kardia SLR, Kooperberg C, Laakso M, Lettre G, Madden P, McGue M, North K, Posthuma D, Spector T, Stram D, Tobin MD, Weir DR, Kaprio J, Abecasis GR, Liu DJ, Vrieze S.

Biol Psychiatry. 2019 Jun 1;85(11):946-955. doi: 10.1016/j.biopsych.2018.11.024. Epub 2018 Dec 6.

PMID:
30679032
4.

Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.

Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, Datta G, Davila-Velderrain J, McGuire D, Tian C, Zhan X; 23andMe Research Team; HUNT All-In Psychiatry, Choquet H, Docherty AR, Faul JD, Foerster JR, Fritsche LG, Gabrielsen ME, Gordon SD, Haessler J, Hottenga JJ, Huang H, Jang SK, Jansen PR, Ling Y, Mägi R, Matoba N, McMahon G, Mulas A, Orrù V, Palviainen T, Pandit A, Reginsson GW, Skogholt AH, Smith JA, Taylor AE, Turman C, Willemsen G, Young H, Young KA, Zajac GJM, Zhao W, Zhou W, Bjornsdottir G, Boardman JD, Boehnke M, Boomsma DI, Chen C, Cucca F, Davies GE, Eaton CB, Ehringer MA, Esko T, Fiorillo E, Gillespie NA, Gudbjartsson DF, Haller T, Harris KM, Heath AC, Hewitt JK, Hickie IB, Hokanson JE, Hopfer CJ, Hunter DJ, Iacono WG, Johnson EO, Kamatani Y, Kardia SLR, Keller MC, Kellis M, Kooperberg C, Kraft P, Krauter KS, Laakso M, Lind PA, Loukola A, Lutz SM, Madden PAF, Martin NG, McGue M, McQueen MB, Medland SE, Metspalu A, Mohlke KL, Nielsen JB, Okada Y, Peters U, Polderman TJC, Posthuma D, Reiner AP, Rice JP, Rimm E, Rose RJ, Runarsdottir V, Stallings MC, Stančáková A, Stefansson H, Thai KK, Tindle HA, Tyrfingsson T, Wall TL, Weir DR, Weisner C, Whitfield JB, Winsvold BS, Yin J, Zuccolo L, Bierut LJ, Hveem K, Lee JJ, Munafò MR, Saccone NL, Willer CJ, Cornelis MC, David SP, Hinds DA, Jorgenson E, Kaprio J, Stitzel JA, Stefansson K, Thorgeirsson TE, Abecasis G, Liu DJ, Vrieze S.

Nat Genet. 2019 Feb;51(2):237-244. doi: 10.1038/s41588-018-0307-5. Epub 2019 Jan 14.

5.

Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci.

Erzurumluoglu AM, Liu M, Jackson VE, Barnes DR, Datta G, Melbourne CA, Young R, Batini C, Surendran P, Jiang T, Adnan SD, Afaq S, Agrawal A, Altmaier E, Antoniou AC, Asselbergs FW, Baumbach C, Bierut L, Bertelsen S, Boehnke M, Bots ML, Brazel DM, Chambers JC, Chang-Claude J, Chen C, Corley J, Chou YL, David SP, de Boer RA, de Leeuw CA, Dennis JG, Dominiczak AF, Dunning AM, Easton DF, Eaton C, Elliott P, Evangelou E, Faul JD, Foroud T, Goate A, Gong J, Grabe HJ, Haessler J, Haiman C, Hallmans G, Hammerschlag AR, Harris SE, Hattersley A, Heath A, Hsu C, Iacono WG, Kanoni S, Kapoor M, Kaprio J, Kardia SL, Karpe F, Kontto J, Kooner JS, Kooperberg C, Kuulasmaa K, Laakso M, Lai D, Langenberg C, Le N, Lettre G, Loukola A, Luan J, Madden PAF, Mangino M, Marioni RE, Marouli E, Marten J, Martin NG, McGue M, Michailidou K, Mihailov E, Moayyeri A, Moitry M, Müller-Nurasyid M, Naheed A, Nauck M, Neville MJ, Nielsen SF, North K, Perola M, Pharoah PDP, Pistis G, Polderman TJ, Posthuma D, Poulter N, Qaiser B, Rasheed A, Reiner A, Renström F, Rice J, Rohde R, Rolandsson O, Samani NJ, Samuel M, Schlessinger D, Scholte SH, Scott RA, Sever P, Shao Y, Shrine N, Smith JA, Starr JM, Stirrups K, Stram D, Stringham HM, Tachmazidou I, Tardif JC, Thompson DJ, Tindle HA, Tragante V, Trompet S, Turcot V, Tyrrell J, Vaartjes I, van der Leij AR, van der Meer P, Varga TV, Verweij N, Völzke H, Wareham NJ, Warren HR, Weir DR, Weiss S, Wetherill L, Yaghootkar H, Yavas E, Jiang Y, Chen F, Zhan X, Zhang W, Zhao W, Zhao W, Zhou K, Amouyel P, Blankenberg S, Caulfield MJ, Chowdhury R, Cucca F, Deary IJ, Deloukas P, Di Angelantonio E, Ferrario M, Ferrières J, Franks PW, Frayling TM, Frossard P, Hall IP, Hayward C, Jansson JH, Jukema JW, Kee F, Männistö S, Metspalu A, Munroe PB, Nordestgaard BG, Palmer CNA, Salomaa V, Sattar N, Spector T, Strachan DP; Understanding Society Scientific Group, EPIC-CVD, GSCAN, Consortium for Genetics of Smoking Behaviour, CHD Exome+ consortium, van der Harst P, Zeggini E, Saleheen D, Butterworth AS, Wain LV, Abecasis GR, Danesh J, Tobin MD, Vrieze S, Liu DJ, Howson JMM.

Mol Psychiatry. 2019 Jan 7. doi: 10.1038/s41380-018-0313-0. [Epub ahead of print]

6.

From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.

Salloum NC, Buchalter ELF, Chanani S, Espejo G, Ismail MS, Laine RO, Nageeb M, Srivastava AB, Trapp N, Trillo L, Vance E, Wenzinger M, Hartz SM, David SP, Chen LS.

Pharmacogenomics. 2018 Jul 1;19(10):861-871. doi: 10.2217/pgs-2018-0023. Epub 2018 Jun 19.

7.

Clinical and Personal Utility of Genetic Risk Testing.

David SP, Palaniappan L.

Am Fam Physician. 2018 May 1;97(9):600-602. No abstract available.

8.

Potential Reporting Bias in Neuroimaging Studies of Sex Differences.

David SP, Naudet F, Laude J, Radua J, Fusar-Poli P, Chu I, Stefanick ML, Ioannidis JPA.

Sci Rep. 2018 Apr 17;8(1):6082. doi: 10.1038/s41598-018-23976-1.

9.

Patient and provider perspectives on the development of personalized medicine: a mixed-methods approach.

Puryear L, Downs N, Nevedal A, Lewis ET, Ormond KE, Bregendahl M, Suarez CJ, David SP, Charlap S, Chu I, Asch SM, Pakdaman N, Chang SI, Cullen MR, Palaniappan L.

J Community Genet. 2018 Jul;9(3):283-291. doi: 10.1007/s12687-017-0349-x. Epub 2017 Dec 27.

10.

Continuous-wave and passively Q-switched cryogenic Yb:KLu(WO4)2 laser.

Navratil P, Jambunathan V, David SP, Yue F, Serres JM, Mateos X, Aguiló M, Díaz F, Griebner U, Petrov V, Lucianetti A, Mocek T.

Opt Express. 2017 Oct 16;25(21):25886-25893. doi: 10.1364/OE.25.025886.

PMID:
29041251
11.

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.

Schuit E, Panagiotou OA, Munafò MR, Bennett DA, Bergen AW, David SP.

Cochrane Database Syst Rev. 2017 Sep 8;9:CD011823. doi: 10.1002/14651858.CD011823.pub2. Review.

12.

Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.

Chen LS, Zawertailo L, Piasecki TM, Kaprio J, Foreman M, Elliott HR, David SP, Bergen AW, Baurley JW, Tyndale RF, Baker TB, Bierut LJ, Saccone NL; Genetics and Treatment Workgroup of the Society for Research on Nicotine and Tobacco (SRNT).

Nicotine Tob Res. 2018 Mar 6;20(4):414-424. doi: 10.1093/ntr/ntx097. Review.

13.

The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.

Saccone NL, Baurley JW, Bergen AW, David SP, Elliott HR, Foreman MG, Kaprio J, Piasecki TM, Relton CL, Zawertailo L, Bierut LJ, Tyndale RF, Chen LS; Genetics and Treatment Networks of the Society for Research on Nicotine and Tobacco (SRNT).

Nicotine Tob Res. 2018 Mar 6;20(4):403-413. doi: 10.1093/ntr/ntx096. Review.

14.

Novel Methodologies and the Need for Big Data in Nicotine and Tobacco Genetics Research.

David SP.

Nicotine Tob Res. 2017 Apr 1;19(4):385-386. doi: 10.1093/ntr/ntx005. No abstract available.

PMID:
28393169
15.

Extended treatment for cigarette smoking cessation: a randomized control trial.

Laude JR, Bailey SR, Crew E, Varady A, Lembke A, McFall D, Jeon A, Killen D, Killen JD, David SP.

Addiction. 2017 Aug;112(8):1451-1459. doi: 10.1111/add.13806. Epub 2017 May 2.

16.

Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence.

Leyro TM, Crew EE, Bryson SW, Lembke A, Bailey SR, Prochaska JJ, Henriksen L, Fortmann SP, Killen JD, Killen DT, Hall SM, David SP.

BMJ Open. 2016 Jun 29;6(6):e010960. doi: 10.1136/bmjopen-2015-010960.

17.

Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans.

David SP, Wang A, Kapphahn K, Hedlin H, Desai M, Henderson M, Yang L, Walsh KM, Schwartz AG, Wiencke JK, Spitz MR, Wenzlaff AS, Wrensch MR, Eaton CB, Furberg H, Mark Brown W, Goldstein BA, Assimes T, Tang H, Kooperberg CL, Quesenberry CP, Tindle H, Patel MI, Amos CI, Bergen AW, Swan GE, Stefanick ML.

EBioMedicine. 2016 Jan 11;4:153-61. doi: 10.1016/j.ebiom.2016.01.002. eCollection 2016 Feb.

18.
19.

Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial.

Ockene JK, Hayes RB, Churchill LC, Crawford SL, Jolicoeur DG, Murray DM, Shoben AB, David SP, Ferguson KJ, Huggett KN, Adams M, Okuliar CA, Gross RL, Bass PF 3rd, Greenberg RB, Leone FT, Okuyemi KS, Rudy DW, Waugh JB, Geller AC.

J Gen Intern Med. 2016 Feb;31(2):172-181. doi: 10.1007/s11606-015-3508-y.

20.

Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers.

Weng DY, Chen J, Taslim C, Hsu PC, Marian C, David SP, Loffredo CA, Shields PG.

Mol Carcinog. 2016 Oct;55(10):1424-37. doi: 10.1002/mc.22385. Epub 2015 Aug 21.

21.

Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable.

David SP, Johnson SG, Berger AC, Feero WG, Terry SF, Green LA, Phillips RL Jr, Ginsburg GS.

Ann Fam Med. 2015 Jul-Aug;13(4):373-80. doi: 10.1370/afm.1772.

22.

Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students.

Hayes RB, Geller AC, Crawford SL, Jolicoeur DG, Churchill LC, Okuyemi KS, David SP, Adams M, Waugh J, Allen SS, Leone FT, Fauver R, Leung K, Liu Q, Ockene JK.

Prev Med. 2015 Mar;72:56-63. doi: 10.1016/j.ypmed.2014.12.035. Epub 2015 Jan 5.

23.

Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative.

Henderson MT, Kubo JT, Desai M, David SP, Tindle H, Sinha AA, Seiffert-Sinha K, Hou L, Messina C, Saquib N, Stefanick ML, Tang JY.

J Am Acad Dermatol. 2015 Jan;72(1):190-1.e3. doi: 10.1016/j.jaad.2014.09.024. No abstract available.

24.

Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers.

Strong DR, David SP, Johnstone EC, Aveyard P, Murphy MF, Munafò MR.

Nicotine Tob Res. 2015 Jul;17(7):855-61. doi: 10.1093/ntr/ntu256. Epub 2014 Dec 6.

25.

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Zhu AZ, Zhou Q, Cox LS, David SP, Ahluwalia JS, Benowitz NL, Tyndale RF.

Clin Pharmacol Ther. 2014 Aug;96(2):256-65. doi: 10.1038/clpt.2014.88. Epub 2014 Apr 14.

26.

Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Xu X, Clark US, David SP, Mulligan RC, Knopik VS, McGeary J, MacKillop J, McCaffery J, Niaura RS, Sweet LH.

Nicotine Tob Res. 2014 Jul;16(7):939-47. doi: 10.1093/ntr/ntu010. Epub 2014 Mar 22.

27.

Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention.

Ioannidis JP, Munafò MR, Fusar-Poli P, Nosek BA, David SP.

Trends Cogn Sci. 2014 May;18(5):235-41. doi: 10.1016/j.tics.2014.02.010. Epub 2014 Mar 18. Review.

28.

Systematic review and meta-analysis of opioid antagonists for smoking cessation.

David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ.

BMJ Open. 2014 Mar 14;4(3):e004393. doi: 10.1136/bmjopen-2013-004393. Review.

29.

Clinical interpretation and implications of whole-genome sequencing.

Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, Caleshu C, Kingham K, Klein TE, Whirl-Carrillo M, Sakamoto K, Wheeler MT, Butte AJ, Ford JM, Boxer L, Ioannidis JP, Yeung AC, Altman RB, Assimes TL, Snyder M, Ashley EA, Quertermous T.

JAMA. 2014 Mar 12;311(10):1035-45. doi: 10.1001/jama.2014.1717.

30.

Teaching tobacco dependence treatment and counseling skills during medical school: rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial.

Hayes RB, Geller A, Churchill L, Jolicoeur D, Murray DM, Shoben A, David SP, Adams M, Okuyemi K, Fauver R, Gross R, Leone F, Xiao R, Waugh J, Crawford S, Ockene JK.

Contemp Clin Trials. 2014 Mar;37(2):284-93. doi: 10.1016/j.cct.2014.01.008. Epub 2014 Jan 31.

31.

Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?

David SP.

Addiction. 2014 Jan;109(1):138-9. doi: 10.1111/add.12390. No abstract available.

PMID:
24438115
32.

Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders.

Fusar-Poli P, Radua J, Frascarelli M, Mechelli A, Borgwardt S, Di Fabio F, Biondi M, Ioannidis JP, David SP.

Hum Brain Mapp. 2014 Jul;35(7):3052-65. doi: 10.1002/hbm.22384. Epub 2013 Oct 7.

PMID:
24123491
33.

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.

David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R.

Addiction. 2013 Dec;108(12):2202-11. doi: 10.1111/add.12325. Epub 2013 Sep 18.

34.

Potential reporting bias in fMRI studies of the brain.

David SP, Ware JJ, Chu IM, Loftus PD, Fusar-Poli P, Radua J, Munafò MR, Ioannidis JP.

PLoS One. 2013 Jul 25;8(7):e70104. doi: 10.1371/journal.pone.0070104. Print 2013.

35.

No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Phipps AI, David SP, Hsu L, Harrison TA, Hutter CM, Duggan DJ, White E, Chan AT, Peters U.

Menopause. 2014 Apr;21(4):415-20. doi: 10.1097/GME.0b013e31829e498d.

36.

Opioid antagonists for smoking cessation.

David SP, Lancaster T, Stead LF, Evins AE, Prochaska JJ.

Cochrane Database Syst Rev. 2013 Jun 6;(6):CD003086. doi: 10.1002/14651858.CD003086.pub3. Review.

37.

Biomarkers for smoking cessation.

Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S.

Clin Pharmacol Ther. 2013 Jun;93(6):526-38. doi: 10.1038/clpt.2013.57. Epub 2013 Mar 18. Review.

38.

Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study.

McClure JB, Swan GE, St John J, Fauver R, Javitz HS, Bergen AW, Nishita D, Niaura R, Munafò MR, David SP.

Nicotine Tob Res. 2013 Feb;15(2):518-26. doi: 10.1093/ntr/nts173. Epub 2012 Sep 4.

39.

Genome-wide meta-analyses of smoking behaviors in African Americans.

David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasberger JL, Brown WM, Petruzella S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV, Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N, Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M, Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA, John EM, Kittles R, Kolb S, Kolonel LN, Le Marchand L, Liu Y, Lohman KK, McKnight B, Millikan RC, Murphy A, Neslund-Dudas C, Nyante S, Press M, Psaty BM, Rao DC, Redline S, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B, Stanford JL, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF, Witte JS, Yamamura Y, Yanek LR, Yu K, Zheng W, Ziegler RG, Zonderman AB, Jorgenson E, Haiman CA, Furberg H.

Transl Psychiatry. 2012 May 22;2:e119. doi: 10.1038/tp.2012.41.

40.

The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers.

MacKillop J, Amlung MT, Wier LM, David SP, Ray LA, Bickel WK, Sweet LH.

Psychiatry Res. 2012 Apr 30;202(1):20-9. doi: 10.1016/j.pscychresns.2011.10.003. Epub 2012 May 26.

41.

PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

McDonagh EM, Wassenaar C, David SP, Tyndale RF, Altman RB, Whirl-Carrillo M, Klein TE.

Pharmacogenet Genomics. 2012 Sep;22(9):695-708. doi: 10.1097/FPC.0b013e3283540217. Review. No abstract available.

42.

Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25.

Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Chen YT, Cheng YC, Cho YS, David SP, Duan J, Eaton CB, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ, Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, Rice TK, Schwantes-An TH, Shete SS, Shi J, Spitz MR, Sun YV, Tsai FJ, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC, Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu JY, Yokota J, Amos CI, Bierut LJ.

Genet Epidemiol. 2012 May;36(4):340-51. doi: 10.1002/gepi.21627. Erratum in: Genet Epidemiol. 2012 Jul;36(5):525-6.

43.

Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers.

Liu T, Tyndale RF, David SP, Wang H, Yu XQ, Chen W, Wen XZ, Chen WQ.

J Hum Hypertens. 2013 Jan;27(1):24-30. doi: 10.1038/jhh.2011.111. Epub 2012 Jan 5.

44.

Chronic psychosocial stressors and salivary biomarkers in emerging adults.

Bergen AW, Mallick A, Nishita D, Wei X, Michel M, Wacholder A, David SP, Swan GE, Reid MW, Simons A, Andrews JA.

Psychoneuroendocrinology. 2012 Aug;37(8):1158-70. doi: 10.1016/j.psyneuen.2011.11.010. Epub 2011 Dec 14.

45.

Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers.

Liu T, David SP, Tyndale RF, Wang H, Yu XQ, Chen W, Zhou Q, Chen WQ.

Ann Behav Med. 2012 Apr;43(2):253-61. doi: 10.1007/s12160-011-9318-5.

46.

Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways.

Liu T, Chen WQ, David SP, Tyndale RF, Wang H, Chen YM, Yu XQ, Chen W, Zhou Q, Ling WH.

Eur J Endocrinol. 2011 Dec;165(6):961-7. doi: 10.1530/EJE-11-0596. Epub 2011 Sep 29.

47.

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.

Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, Whirl-Carrillo M, Wheeler MT, Dudley JT, Byrnes JK, Cornejo OE, Knowles JW, Woon M, Sangkuhl K, Gong L, Thorn CF, Hebert JM, Capriotti E, David SP, Pavlovic A, West A, Thakuria JV, Ball MP, Zaranek AW, Rehm HL, Church GM, West JS, Bustamante CD, Snyder M, Altman RB, Klein TE, Butte AJ, Ashley EA.

PLoS Genet. 2011 Sep;7(9):e1002280. doi: 10.1371/journal.pgen.1002280. Epub 2011 Sep 15.

48.

Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women.

Janes AC, Smoller JW, David SP, Frederick BD, Haddad S, Basu A, Fava M, Evins AE, Kaufman MJ.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):7-13. doi: 10.1016/j.drugalcdep.2011.06.009. Epub 2011 Jul 20.

49.
50.

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

David SP, Johnstone EC, Churchman M, Aveyard P, Murphy MF, Munafò MR.

Nicotine Tob Res. 2011 Mar;13(3):157-67. doi: 10.1093/ntr/ntq246. Epub 2011 Jan 25. Review.

Supplemental Content

Loading ...
Support Center